NCT06703970 - Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

July 16, 2024

Study Completion Date

July 16, 2024

Conditions

Knee Osteoarthritis (OA)

Interventions

DRUG

Corticosteroid Injection

5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl Injection, USP)

DEVICE

Platelet Rich Plasma Joint Injection

\~3 milliliters (mL) injection of autologous PRP Magellan Autologous Concentration System, ISTO Biologics

Trial Locations (1)

21215

Sinai Hospital of Baltimore, Baltimore